"Effect of the ChemoFit Kids program on quality of life in children and adolescents with chemotherapy-induced polyneuropathy- a real case study"

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00028949

Enrollment

Registered

2022-06-17

Start date

2022-04-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G62.0 C91.0

Interventions

Group 1: Perform ChemoFit-Kids program daily

Eligibility

Sex/Gender

All

Age

10 Years to 17 Years

Inclusion criteria

Inclusion criteria: The children and adolescents should be male and/or female and between 10 and 17 years old, have received chemotherapy due to cancer, in the best case acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML), and have also been diagnosed with CIPN with sensory, motor and/or autonomic symptoms.

Exclusion criteria

Exclusion criteria: stationary setting currently undergoing chemotherapeutic treatment

Design outcomes

Primary

Measure	Time frame
Quality of life by KINDL questionnaire at baseline (t0), after 4 weeks (t1) and after 8 weeks (t2). Feasibility by CF-Chatters program at t2.	—

Secondary

Measure	Time frame
ped-mTNS and CTCAE at t0, t1 and t2	—

Countries

Germany

Contacts

Public ContactThorsten Langer

Klinik für Kinder- und JugendmedizinLeitung des AG Spätfolgen in der Pädiatrischen OnkologieStellvertretender Leiter Pädiatrische Hämatologie und Onkologie UKSH Lübeck

thorsten.Langer@uksh.de045150042816

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026